Background The diagnostic performance of contrast medium–free biparametric magnetic
resonance imaging (bpMRI; combining T2-weighted imaging [T2WI] and diffusion-weighted …

Bladder cancer (BC), predominantly comprising urothelial carcinomas (UCs), ranks as the
tenth most common cancer worldwide. UCs with variant histology (variant UC), including …

Background Sarcomatoid urothelial carcinoma (SUC) is a rare and highly malignant form of
bladder cancer with a poor prognosis. Currently, there is limited information on the imaging …

Transurethral resection of bladder tumor (TURBT) is the essential first step in the current
algorithm for the management of bladder cancer (BC). However, despite its necessity and …

Abstract Objectives Urachal carcinomas (UrC) are rare non-urothelial bladder neoplasms,
however the potential role for MR imaging in UrC has not been well established. Our …

Background Urachal tumors are exceedingly rare, and adenocarcinoma is the most common
malignant urachal neoplasm. Here, an especially rare patient of primary urachal …

Abstract Vesical Imaging Reporting and Data System (VI-RADS) shows good potential in
determining muscle-invasive bladder cancer (MIBC) patients. However, whether VI-RADS …

Background Neoadjuvant chemotherapy (NAC) before radical cystectomy is standard of
care in patients with muscle-invasive bladder cancer (MIBC). Response assessment after …

Materials and methods A literature review was conducted to create a comprehensive list of
the recent research regarding PUC. The electronic database PubMed was searched on …

Introduction We aimed to provide a pathological perspective on the management of muscle-
invasive bladder cancer (MIBC) by correlating the prechemotherapy transurethral resection …